Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New agents for inhibiting EGF receptor-mediated abnormal cell growth

June 25, 1998

More telomerase inhibitors added to the Geron pipeline

June 25, 1998

Potent angiogenesis inhibitor AG-3340 profiled at NCI-EORTC symposium

June 24, 1998

Introgen Therapeutics acquires exclusive option to license PTEN gene

June 24, 1998

Phase II evaluation of carzelesin in NHL

June 24, 1998

Miproxifene phosphate, a promising treatment for breast cancer

June 24, 1998

Management strategy including hydroxyurea successful in unresectable meningioma

June 24, 1998

S-16020-2: a topoisomerase II inhibitor selective for renal cancers heads for phase II testing

June 24, 1998

Select Therapeutics signs agreement for cancer vaccine platform technology

June 24, 1998

Lilly presents results of first clinical trial evaluating the MDR modulator LY-335979

June 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...